search
Back to results

Team-based Inpatient ARTAS (ARTAS)

Primary Purpose

HIV Infections, Inpatient Facility Diagnoses

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Team Based Inpatient ARTAS
Standard of Care
Sponsored by
Loma Linda University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for HIV Infections focused on measuring HIV, linkage to care, hospital readmission

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 18 years of age or greater newly diagnosed HIV Known diagnosis of HIV not on ART within 30 days of admission Known HIV and not virally suppressed based on interview Known HIV and has not been under the care of an HIV specialist within the past 6 months Exclusion Criteria: All three criteria must be present for exclusion: virally suppressed actively taking ART are under active care of an HIV specialist within the last 6 months Less than 18 years of age (stand alone exclusion)

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Standard of Care Historic Control

    Team based inpatient ARTAS

    Arm Description

    Control group will get treatment as usual, which consists of medical care by primary admitting service

    Eligible patients after the study consent process will receive Antiretroviral Treatment Access Study (ARTAS) intervention by social-worker and a medical consultation by an infectious disease physician

    Outcomes

    Primary Outcome Measures

    Rate of linkage to HIV care post discharge
    Subject had one visit with HIV specialist post hospital discharge. This will be determined per medical chart review and phone interview with subject

    Secondary Outcome Measures

    Readmission Rate after initial post-study hospitalization
    Subject had one emergency room visit or one inpatient admission post hospital discharge. This will be determined per medical chart review and phone interview with subject.

    Full Information

    First Posted
    May 10, 2023
    Last Updated
    September 6, 2023
    Sponsor
    Loma Linda University
    Collaborators
    Gilead Sciences
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05866523
    Brief Title
    Team-based Inpatient ARTAS
    Acronym
    ARTAS
    Official Title
    Team-based Inpatient Anti-Retroviral Treatment and Access to Services (ARTAS)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    December 2023 (Anticipated)
    Primary Completion Date
    August 2025 (Anticipated)
    Study Completion Date
    August 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Loma Linda University
    Collaborators
    Gilead Sciences

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Exploring the effect of team-based ARTAS intervention in an inpatient setting on HIV linkage to care and hospital readmission rates.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    HIV Infections, Inpatient Facility Diagnoses
    Keywords
    HIV, linkage to care, hospital readmission

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Sequential Assignment
    Model Description
    This is a prospective, observational cohort study design with patients enrolled at Loma Linda University Medical Center (LLUMC), evaluating a multidisciplinary inpatient linkage to care program compared to historical control.
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    300 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Standard of Care Historic Control
    Arm Type
    Active Comparator
    Arm Description
    Control group will get treatment as usual, which consists of medical care by primary admitting service
    Arm Title
    Team based inpatient ARTAS
    Arm Type
    Active Comparator
    Arm Description
    Eligible patients after the study consent process will receive Antiretroviral Treatment Access Study (ARTAS) intervention by social-worker and a medical consultation by an infectious disease physician
    Intervention Type
    Behavioral
    Intervention Name(s)
    Team Based Inpatient ARTAS
    Intervention Description
    Infectious Disease Team will provide inpatient consultation. Social Work Team will provide 1 session of case management inpatient and up to 5 case management sessions within 90 days post discharge or until the client is linked to medical care as evidenced by visit with HIV specialist within 90 days post discharge.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Standard of Care
    Intervention Description
    Subject admitted and seen by routine inpatient medical service.
    Primary Outcome Measure Information:
    Title
    Rate of linkage to HIV care post discharge
    Description
    Subject had one visit with HIV specialist post hospital discharge. This will be determined per medical chart review and phone interview with subject
    Time Frame
    Up to 90 days post-study enrollment hospitalization discharge
    Secondary Outcome Measure Information:
    Title
    Readmission Rate after initial post-study hospitalization
    Description
    Subject had one emergency room visit or one inpatient admission post hospital discharge. This will be determined per medical chart review and phone interview with subject.
    Time Frame
    Up to 90 days post-study enrollment hospitalization discharge

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: 18 years of age or greater newly diagnosed HIV Known diagnosis of HIV not on ART within 30 days of admission Known HIV and not virally suppressed based on interview Known HIV and has not been under the care of an HIV specialist within the past 6 months Exclusion Criteria: All three criteria must be present for exclusion: virally suppressed actively taking ART are under active care of an HIV specialist within the last 6 months Less than 18 years of age (stand alone exclusion)
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jennifer Veltman, MD
    Phone
    909 558 4000
    Ext
    14912
    Email
    jveltman@llu.edu

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Team-based Inpatient ARTAS

    We'll reach out to this number within 24 hrs